Targeted delivery of gemcitabine to lung cancer cells via a hyaluronic acid-based nanoplatform
RSC Advances · 2026 · 16 (28) · 25944-25963
DOI: 10.1039/d6ra02076c ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Advances, 2026. Verfasst von Fengbo Yu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Collaborative Innovation Center for Development and Application of Northern Medicine Resources, Mudanjiang Medical University Mudanjiang Heilongjiang…. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Natural Science Foundation of Heilongjiang Province.
Abstract (Originalsprache)
A CD44-targeted nanoplatform (GEM@HA-(HAP/PSI)) with a high drug-loading HAP core and HA–PSI shell enables active targeting, pH-responsive release, CD44-mediated endocytosis, superior in vitro antitumor activity and in vivo tumor suppression.
Autor:innen und Institutionen
- Collaborative Innovation Center for Development and Application of Northern Medicine Resources, Mudanjiang Medical University Mudanjiang Heilongjiang Province People's Republic of China.
- School of Pharmacy, Mudanjiang Medical University Mudanjiang Heilongjiang Province People's Republic of China.
- School of Public Health, Mudanjiang Medical University Mudanjiang Heilongjiang Province People's Republic of China drwang1982@126.com.
- Hongqi Hospital, Mudanjiang Medical University Mudanjiang Heilongjiang Province People's Republic of China.
ORCID-Profile: Qiang Wang
Förderung
- Natural Science Foundation of Heilongjiang Province
Zitieren
APA
Yu, F., Cao, J., Fan, X., Gao, J., Liu, G., Lin, C., Zhu, Y., & Wang, Q. (2026). Targeted delivery of gemcitabine to lung cancer cells via a hyaluronic acid-based nanoplatform. RSC Advances, 16(28), 25944-25963. https://doi.org/10.1039/d6ra02076c
Vancouver
Yu F, Cao J, Fan X, Gao J, Liu G, Lin C, et al. Targeted delivery of gemcitabine to lung cancer cells via a hyaluronic acid-based nanoplatform. RSC Advances. 2026;16(28):25944-25963. doi:10.1039/d6ra02076c
BibTeX
@article{Yu2026,
author = {Yu, Fengbo and Cao, Jingdan and Fan, Xingjun and Gao, Junxia and Liu, Guifang and Lin, Chonghuan and Zhu, Ying and Wang, Qiang},
title = {Targeted delivery of gemcitabine to lung cancer cells via a hyaluronic acid-based nanoplatform},
journal = {RSC Advances},
year = {2026},
volume = {16},
number = {28},
pages = {25944--25963},
doi = {10.1039/d6ra02076c}
}
EUVIMED